NETRI is an industrial innovation company that provides analysis methods based on human cells to encode and explore complex pathways of human neurons, and provides and develops treatment methods for cross industry applications in industries such as pharmaceuticals, nutrition, and skin cosmetics. From discovery to clinical stage, NETRI provides high-throughput microfluidic devices and research and development services necessary for human digitization.
NETRI, with its full process solution, integrates its independently developed organ chip technology into customers' standardized processes, enabling the study of the relationship between human biology and pathophysiology in the laboratory. By providing predictive data and platforms, it can understand the patterns of action during discovery, preclinical, or clinical stages.
- Conference Preview | Premedlab invites you to attend the 12th Munich Shanghai Analytical Biochemistry Exhibition
- Conference Preview | PremedLab invites you to attend the Beijing Yizhuang Summit on Cell Genes and Nucleic Acid Drugs
- Conference Preview | PremedLab invites you to attend the 14th Annual Meetting of CSSCR
- Binaree Organization Transparency Reagent - Summer Promotion Begins!
- The new high-precision SPR detection platform for 2024 is here!!
- Meeting Announcement | Premedlab cordially invites you to participate in the 2nd Molecular Interaction Innovation Technology and Frontier Application Network Seminar
- Application for limited time of Corebiogenesis trial installation | GMP grade FGF-2 STAB with no animal source, thermal stability, and high activity - new gold standard for stem cell culture
- CELLnTEC new product launch | Corticosteroid free epithelial cell proliferation medium
